Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital ...

November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...

Gary Hattersley, chief scientific officer at Nuvation Bio (NYSE:NUVB), exercised and immediately sold 100,000 shares of Class A common stock in an open-market derivative transaction on October 27, ...

If the human capital and quality of life theories are right, the Midwest would be a half-century into a century-long period ...

The healthtech industry is on track to triple from $352 in 2025 to over $1.1T by 2032, driven by critical needs in provider capacity, aging populations, and chronic disease management.

Pakistan’s booming infrastructure hides a darker truth — highways, housing projects, and development grants are doubling as ...

It is nearly three times the global average of 5.5 per cent. The figure speaks eloquently of the alarming progression of the country from transit camp to consumption home. Not only are Nigerians ...

During her 2025 State of the School address, Allison Brashear, MD, MBA, evoked the image of a mighty oak tree when describing the current state of the Jacobs School of Medicine and Biomedical Sciences ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...